 |
The third film in the series, Sonic the Hedgehog 3, recently surpassed $100M at the international box office, and has earned over $187M domestically for a cumulative worldwide gross to-date of over $312M
HOLLYWOOD, Calif., Jan. 6, 2025 /PRNewswire/ -- Paramount Pictures today announced that its Sonic the Hedgehog film franchise, based on the SEGA video game, has surpassed $1B in total box office receipts worldwide, as Sonic the Hedgehog 3 continues to draw audiences to theatres across the globe.
Released in February 2020 and April 2022, respectively, Sonic the Hedgehog and Sonic the Hedgehog 2 earned a combined $725.2M globally and generated $181M in consumer spending from home entertainment rentals and purchases. Last April, the spinoff series "Knuckles" debuted on Paramount +, earning over 11M total global hours in its first 28 days streaming, making it the #1 Kids & Family series ever in terms of hours on the platform.
Sonic the Hedgehog 3 released theatrically last month to an "A" CinemaScore and boasts a franchise-best Certified Fresh 86% Rotten Tomatoes critics' score (tying it for #1 as the best-reviewed video game film adaptation of all time), and a franchise-best 96% Verified Hot Popcornmeter score, earning over $312M globally to-date. The film opened to #1 at the domestic box office, followed by the franchise's biggest international opening, with just 84% of the international footprint the following week. On a like-for-like basis, including previews, for the same group of markets this result was 83% ahead of Sonic the Hedgehog 2. The movie also reached $100M in international box office gross more quickly than its predecessors.
The latest film in the series features the return of the original cast, including Jim Carrey as Dr. Robotnik. The film stars Carrey, Ben Schwartz, Krysten Ritter, Lee Majdoub, Natasha Rothwell, Adam Pally, Shemar Moore, Colleen O'Shaughnessey, Alyla Browne, James Wolk with James Marsden, Tika Sumpter, Idris Elba and Keanu Reeves. It is directed by Jeff Fowler, who has directed all three films in the series, with a screenplay by Pat Casey & Josh Miller and John Whittington, story by Pat Casey & Josh Miller, and produced by Neal H. Moritz, Toby Ascher, Toru Nakahara, and Hitoshi Okuno.
In the film, Sonic, Knuckles, and Tails reunite against a powerful new adversary, Shadow, a mysterious villain with powers unlike anything they have faced before. With their abilities outmatched in every way, Team Sonic must seek out an unlikely alliance in hopes of stopping Shadow and protecting the planet.
Recently, the studio announced that development is underway for a fourth installment of the Sonic the Hedgehog film series.
Said Moritz and Ascher, "We are so overjoyed with the amazing response to the Sonic the Hedgehog films from audiences and fans around the world and are proud to be part of the incredible, world-class filmmaking team that has come together to build this franchise. We make these movies for the fans; and their passion, support and love for these characters is what drives us every day to continue creating the fast, funny, and action-packed stories that make up the ever-expanding Sonic Universe."
Said Paramount Pictures President & CEO Brian Robbins, "The Sonic the Hedgehog franchise has become an unstoppable cultural force with limitless potential. Congratulations to our partners at SEGA, our filmmaking team, including Neal, Toby, and Jeff, who have revolutionized the heights that Sonic can reach, and the legions of loyal and devoted fans who have helped guide us every step of the way. As each chapter of Sonic's adventures continues to raise the bar, we're incredibly proud and excited to continue delivering stories and characters that resonate with audiences around the world."
About Paramount Pictures
Paramount Pictures Corporation (PPC), a global producer and distributor of filmed entertainment, is a unit of Paramount Global (NASDAQ: PARA, PARAA), a leading global media and entertainment company that creates premium content and experiences for audiences worldwide. Paramount Pictures has some of the most powerful brands in filmed entertainment, including Paramount Pictures, Paramount Animation, and Paramount Players. PPC operations also include Paramount Home Entertainment, Paramount Pictures International, Paramount Licensing Inc., and Paramount Studio Group.
The third film in the series, Sonic the Hedgehog 3, recently surpassed $100M at the international box office, and has earned over $187M domestically for a cumulative worldwide gross to-date of over $312M
HOLLYWOOD, Calif., Jan. 6, 2025 /PRNewswire/ -- Paramount Pictures today announced that its Sonic the Hedgehog film franchise, based on the SEGA video game, has surpassed $1B in total box office receipts worldwide, as Sonic the Hedgehog 3 continues to draw audiences to theatres across the globe.
Released in February 2020 and April 2022, respectively, Sonic the Hedgehog and Sonic the Hedgehog 2 earned a combined $725.2M globally and generated $181M in consumer spending from home entertainment rentals and purchases. Last April, the spinoff series "Knuckles" debuted on Paramount +, earning over 11M total global hours in its first 28 days streaming, making it the #1 Kids & Family series ever in terms of hours on the platform.
Sonic the Hedgehog 3 released theatrically last month to an "A" CinemaScore and boasts a franchise-best Certified Fresh 86% Rotten Tomatoes critics' score (tying it for #1 as the best-reviewed video game film adaptation of all time), and a franchise-best 96% Verified Hot Popcornmeter score, earning over $312M globally to-date. The film opened to #1 at the domestic box office, followed by the franchise's biggest international opening, with just 84% of the international footprint the following week. On a like-for-like basis, including previews, for the same group of markets this result was 83% ahead of Sonic the Hedgehog 2. The movie also reached $100M in international box office gross more quickly than its predecessors.
The latest film in the series features the return of the original cast, including Jim Carrey as Dr. Robotnik. The film stars Carrey, Ben Schwartz, Krysten Ritter, Lee Majdoub, Natasha Rothwell, Adam Pally, Shemar Moore, Colleen O'Shaughnessey, Alyla Browne, James Wolk with James Marsden, Tika Sumpter, Idris Elba and Keanu Reeves. It is directed by Jeff Fowler, who has directed all three films in the series, with a screenplay by Pat Casey & Josh Miller and John Whittington, story by Pat Casey & Josh Miller, and produced by Neal H. Moritz, Toby Ascher, Toru Nakahara, and Hitoshi Okuno.
In the film, Sonic, Knuckles, and Tails reunite against a powerful new adversary, Shadow, a mysterious villain with powers unlike anything they have faced before. With their abilities outmatched in every way, Team Sonic must seek out an unlikely alliance in hopes of stopping Shadow and protecting the planet.
Recently, the studio announced that development is underway for a fourth installment of the Sonic the Hedgehog film series.
Said Moritz and Ascher, "We are so overjoyed with the amazing response to the Sonic the Hedgehog films from audiences and fans around the world and are proud to be part of the incredible, world-class filmmaking team that has come together to build this franchise. We make these movies for the fans; and their passion, support and love for these characters is what drives us every day to continue creating the fast, funny, and action-packed stories that make up the ever-expanding Sonic Universe."
Said Paramount Pictures President & CEO Brian Robbins, "The Sonic the Hedgehog franchise has become an unstoppable cultural force with limitless potential. Congratulations to our partners at SEGA, our filmmaking team, including Neal, Toby, and Jeff, who have revolutionized the heights that Sonic can reach, and the legions of loyal and devoted fans who have helped guide us every step of the way. As each chapter of Sonic's adventures continues to raise the bar, we're incredibly proud and excited to continue delivering stories and characters that resonate with audiences around the world."
About Paramount Pictures
Paramount Pictures Corporation (PPC), a global producer and distributor of filmed entertainment, is a unit of Paramount Global (NASDAQ: PARA, PARAA), a leading global media and entertainment company that creates premium content and experiences for audiences worldwide. Paramount Pictures has some of the most powerful brands in filmed entertainment, including Paramount Pictures, Paramount Animation, and Paramount Players. PPC operations also include Paramount Home Entertainment, Paramount Pictures International, Paramount Licensing Inc., and Paramount Studio Group.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
PARAMOUNT PICTURES ANNOUNCES SONIC THE HEDGEHOG FILM FRANCHISE ZOOMS PAST $1 BILLION IN WORLDWIDE BOX OFFICE GROSS
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
